Vertos Medical completed a US $28MM financing round. Funds will support commercialization of the mild® outpatient procedure for the minimally invasive treatment of stenosis.
Creative Medical Technology filed a patent application covering synergy between intradiscal stem cell injections and stimulation of blood vessel formation around the spine.
ASC Biosciences partnered with Stem Cell Development Fund to receive US $1.5MM to support development and marketing of its Multipotent Adult Stem Cell platform.
Premier is now offering Bioventus’ full surgical orthobiologics product portfolio to its U.S. membership, comprising 3,750 hospitals and >130,000 provider organizations.Â